Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Total Debt (2019 - 2025)

Bioadaptives' Total Debt history spans 7 years, with the latest figure at $967406.0 for Q3 2025.

  • For Q3 2025, Total Debt fell 5.94% year-over-year to $967406.0; the TTM value through Sep 2025 reached $967406.0, down 5.94%, while the annual FY2024 figure was $1.1 million, 7.71% up from the prior year.
  • Total Debt for Q3 2025 was $967406.0 at Bioadaptives, up from $860636.0 in the prior quarter.
  • Across five years, Total Debt topped out at $1.1 million in Q2 2024 and bottomed at $557042.0 in Q4 2021.
  • The 5-year median for Total Debt is $874737.0 (2023), against an average of $860753.3.
  • The largest YoY upside for Total Debt was 25905.05% in 2021 against a maximum downside of 32.65% in 2021.
  • A 5-year view of Total Debt shows it stood at $557042.0 in 2021, then rose by 23.3% to $686856.0 in 2022, then surged by 42.37% to $977872.0 in 2023, then grew by 7.71% to $1.1 million in 2024, then decreased by 8.15% to $967406.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Total Debt are $967406.0 (Q3 2025), $860636.0 (Q2 2025), and $991590.0 (Q1 2025).